State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review

References

• Potter VR. Initiation and promotion in cancer formation: The importance of studies on intercellular communication. Yale J Biol Med. 1980;53(5):367–384.
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvoge W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200(4):373–383.
   PubMed Web of Science ®Google Scholar
• Simons M, Raposo G. Exosomes – vesicular carriers for intercellular communication. Curr Opin Cell Biol. 2009;21(4):575–581.
   PubMed Web of Science ®Google Scholar
• Stahl PD, Raposo G. Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology (Bethesda). 2019;34(3):169–177.
   PubMed Web of Science ®Google Scholar
• Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–579.
   PubMed Web of Science ®Google Scholar
• Gudbergsson JM, Jønsson K, Simonsen JB, et al. Systematic review of targeted extracellular vesicles for drug delivery – considerations on methodological and biological heterogeneity. J Control Release. 2019;306:108–120.
   PubMed Web of Science ®Google Scholar
• Tarasov VV, Svistunov AA, Chubarev VN, et al. Extracellular vesicles in cancer nanomedicine. Semin Cancer Biol. 2019; in press.
   Web of Science ®Google Scholar
• Hood JL. Post isolation modification of exosomes for nanomedicine applications. Nanomedicine (Lond)). 2016;11(13):1745–1756.
   PubMed Web of Science ®Google Scholar
• Ayala-Mar S, Donoso-Quezada J, Gallo-Villanueva RC, et al. Recent advances and challenges in the recovery and purification of cellular exosomes. Electrophoresis. 2019;40(23–24):3036–3049.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18(9):1606–1614.
   PubMed Web of Science ®Google Scholar
• Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio Rerio. Pharm Res. 2015;32(6):2003–2014.
   PubMed Web of Science ®Google Scholar
• Agrawal AK, Aqil F, Jeyabalan J, et al. Milk-derived exosomes for oral delivery of paclitaxel. Nanomed Nanotechnol Biol Med. 2017;13(5):1627–1636.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, et al. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371(1):48–61.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. J Control Release. 2015;207:18–30.
   PubMed Web of Science ®Google Scholar
• Shahabipour F, Banach M, Sahebkar A. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges. Arch Med Sci. 2016;12(6):1324–1326.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Heon M, Zhao Z, et al. Microfluidic engineering of exosomes: editing cellular messages for precision therapeutics. Lab Chip. 2018;18(12):1690–1703.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Bala S, Bukong T, et al. Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomed Nanotechnol Biol Med. 2014;10(7):1517–1527.
   PubMed Web of Science ®Google Scholar
• Wahlgren J, Karlson TDL, Brisslert M, et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res. 2012;40:130.
   PubMed Web of Science ®Google Scholar
• Lamichhane TN, Raiker RS, Jay SM. Exogenous DNA loading into extracellular vesicles via electroporation is size-dependent and enables limited gene delivery. Mol Pharm. 2015;12(10):3650–3657.
   PubMed Web of Science ®Google Scholar
• Hood JL, Scott MJ, Wickline SA. Maximizing exosome colloidal stability following electroporation. Anal Biochem. 2014;448:41–49.
   PubMed Web of Science ®Google Scholar
• Aqil F, Munagala R, Jeyabalan J, et al. Milk exosomes – natural nanoparticles for siRNA delivery. Cancer Lett. 2019;449:186–195.
   PubMed Web of Science ®Google Scholar
• Ding Y, Cao F, Sun H, et al. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Cancer Lett. 2019;442:351–361.
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed Nanotechnol Biol Med. 2016;12(3):655–664.
   PubMed Web of Science ®Google Scholar
• Yang Z, Xie J, Zhu J, et al. Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation. J Control Release. 2016;243:160–171.
   PubMed Web of Science ®Google Scholar
• Didiot MC, Hall LM, Coles AH, et al. Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing. Mol Ther. 2016;24(10):1836–1847.
   PubMed Web of Science ®Google Scholar
• Haraszti RA, Coles A, Aronin N, et al. Loading of extracellular vesicles with chemically stabilized hydrophobic siRNAs for the treatment of disease in the central nervous system. Bio Protoc. 2017;7:1–26.
   Web of Science ®Google Scholar
• Villarroya-Beltri C, Baixauli F, Gutiérrez-Vázquez C, et al. Sorting it out: regulation of exosome loading. Semin Cancer Biol. 2014;28:3–13.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Schorey JS. Targeting soluble proteins to exosomes using a ubiquitin tag. Biotechnol Bioeng. 2016;113(6):1315–1324.
   PubMed Web of Science ®Google Scholar
• Freed EO. Viral late domains. J Virol. 2002;76(10):4679–4687.
   PubMed Web of Science ®Google Scholar
• Sterzenbach U, Putz U, Low LH, et al. Engineered exosomes as vehicles for biologically active proteins. Mol Ther. 2017;25(6):1269–1278.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 2011;19(10):1769–1779.
   PubMed Web of Science ®Google Scholar
• Yim N, Ryu S-W, Choi K, et al. Efficient and rapid cellular delivery of bioactive proteins using EXPLOR: exosomes engineered for protein loading via optically reversible protein-protein interaction. Proceedings: AACR 107th Annual Meeting 2016; April 16–20, 2016. New Orleans, LA; 2016.
   Google Scholar
• Kennedy MJ, Hughes RM, Peteya LA, et al. Rapid blue light induction of protein interactions in living cells. Nat Methods. 2010;7(12):973–975.
   PubMed Web of Science ®Google Scholar
• Yim N, Ryu SW, Choi K, et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun. 2016;7:12277.
   PubMed Web of Science ®Google Scholar
• Huang L, Gu N, Zhang XE, et al. Light-inducible exosome-based vehicle for endogenous RNA loading and delivery to leukemia cells. Adv Funct Mater. 2019;29(9):1807189.
   Web of Science ®Google Scholar
• Lee J, Lee H, Goh U, et al. Cellular engineering with membrane fusogenic liposomes to produce functionalized extracellular vesicles. ACS Appl Mater Interfaces. 2016;8(11):6790–6795.
   PubMed Web of Science ®Google Scholar
• Sato YT, Umezaki K, Sawada S, et al. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933.
   PubMed Web of Science ®Google Scholar
• Keefe AD, Pai S, Ellington A. Aptamers as therapeutics. Nat Rev Drug Discov. 2010;9(7):537–550.
   PubMed Web of Science ®Google Scholar
• Hosseini Shamili F, Alibolandi M, Rafatpanah H, et al. Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward mylein as a platform for reducing multiple sclerosis clinical score. J Control Release. 2019;299:149–164.
   PubMed Web of Science ®Google Scholar
• Burns JC, Friedmann T, Driever W, et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci. 1993;90(17):8033–8037.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hong Y, Nam GH, et al. Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv Mater. 2017;29(13):1605604.
   Web of Science ®Google Scholar
• Levy D. Lysosomal delivery of bioactive proteins to living human cells via engineered exosomes. Santa Clara, CA, USA: Santa Clara University; 2018.
   Google Scholar
• Di Bonito P, Ridolfi B, Columba-Cabezas S, et al. HPV-E7 delivered by engineered exosomes elicits a protective CD8+ T cell-mediated immune response. Viruses. 2015;7(3):1079–1099.
   PubMed Web of Science ®Google Scholar
• Lattanzi L, Federico M. A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles. Vaccine. 2012;30(50):7229–7237.
   PubMed Web of Science ®Google Scholar
• Dai S, Wan T, Wang B, et al. More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA) – specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res. 2005;11(20):7554–7563.
   PubMed Web of Science ®Google Scholar
• Dai S, Zhou X, Wang B, et al. Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8 + CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells. J Mol Med. 2006;84(12):1067–1076.
   PubMed Web of Science ®Google Scholar
• Kim S, Sohn HJ, Lee HJ, et al. Use of engineered exosomes expressing HLA and costimulatory molecules to generate antigen-specific CD8+ T cells for adoptive cell therapy. J Immunother. 2017;40(3):83–93.
   PubMed Web of Science ®Google Scholar
• Wang J, Li W, Lu Z, et al. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis. Nanoscale. 2017;9(40):15598–15605.
   PubMed Web of Science ®Google Scholar
• Tian Y, Li S, Song J, et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35(7):2383–2390.
   PubMed Web of Science ®Google Scholar
• Kooijmans SAA, Fliervoet LAL, Van Der Meel R, et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J Control Release. 2016;224:77–85.
   PubMed Web of Science ®Google Scholar
• Anticoli S, Falcone E, Ruggieri A, et al. Engineered exosomes boost the HCV NS3-specific CD8 + T lymphocyte immunity in humans. Trials Vaccinol. 2016;5:105–110.
   Google Scholar
• Anticoli S, Aricò E, Arenaccio C, et al. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells. J Mol Med. 2018;96(2):211–221.
   PubMed Web of Science ®Google Scholar
• Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, et al. Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol. 2002;14(7):713–722.
   PubMed Web of Science ®Google Scholar
• Vandergriff A, Huang K, Shen D, et al. Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide. Theranostics. 2018;8(7):1869–1878.
   PubMed Web of Science ®Google Scholar
• Kibria G, Lee KE, Ramos EK, et al. Cancer stem cell targeted exosomes for the treatment of metastatic breast cancer. Proc AACR Ann Meet. 2017;77(13):5152.
   Google Scholar
• Wang X, Chen Y, Zhao Z, et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc. 2018;7:e008737.
   PubMed Web of Science ®Google Scholar
• Liang G, Kan S, Zhu Y, et al. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells. Int J Nanomed. 2018;13:585–599.
   PubMed Web of Science ®Google Scholar
• Limoni SK, Moghadam MF, Moazzeni SM, et al. Engineered exosomes for targeted transfer of siRNA to HER2 positive breast cancer cells. Appl Biochem Biotechnol. 2019;187(1):352–364.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li D, Liu Z, et al. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse. Sci Rep. 2015;5:17543.
   PubMed Web of Science ®Google Scholar
• Ohno SI, Takanashi M, Sudo K, et al. Systemically injected exosomes targeted to EGFR deliver antitumor microrna to breast cancer cells. Mol Ther. 2013;21(1):185–191.
   PubMed Web of Science ®Google Scholar
• Bai J, Duan J, Liu R, et al. Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells. Asian J Pharm Sci. 2019; in press.
   PubMed Web of Science ®Google Scholar
• Aqil F, Jeyabalan J, Agrawal AK, et al. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer. Food Funct. 2017;8(11):4100–4107.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Jeyabalan J, et al. Exosomal formulation of anthocyanidins against multiple cancer types. Cancer Lett. 2017;393:94–102.
   PubMed Web of Science ®Google Scholar
• Saari H, Lázaro-Ibáñez E, Viitala T, et al. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells. J Control Release. 2015;220(Pt B):727–737.
   PubMed Web of Science ®Google Scholar
• Pascucci L, Coccè V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262–270.
   PubMed Web of Science ®Google Scholar
• Altanerova U, Jakubechova J, Benejova K, et al. Prodrug suicide gene therapy for cancer targeted intracellular by mesenchymal stem cell exosomes. Int J Cancer. 2019;144(4):897–908.
   PubMed Web of Science ®Google Scholar
• Wang P, Wang H, Huang Q, et al. Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics. 2019;9(6):1714–1727.
   PubMed Web of Science ®Google Scholar
• Cooper JM, Wiklander PBO, Nordin JZ, et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord. 2014;29(12):1476–1485.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341–345.
   PubMed Web of Science ®Google Scholar
• Tian T, Zhang HX, He CP, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy. Biomaterials. 2018;150:137–149.
   PubMed Web of Science ®Google Scholar
• Zhao L, Jiang X, Shi J, et al. Exosomes derived from bone marrow mesenchymal stem cells overexpressing microRNA-25 protect spinal cords against transient ischemia. J Thorac Cardiovasc Surg. 2019;157(2):508–517.
   PubMed Web of Science ®Google Scholar
• Duong N, Curley K, Brown A, et al. Decoy exosomes as a novel biologic reagent to antagonize inflammation. Int J Nanomedicine. 2019;14:3413–3425.
   PubMed Web of Science ®Google Scholar
• Yaddanapudi K, Meng S, Whitt AG, et al. Exosomes from GM-CSF expressing embryonic stem cells are an effective prophylactic vaccine for cancer prevention. Oncoimmunology. 2019;8(3):1561119.
   PubMed Web of Science ®Google Scholar
• Morel L, Regan M, Higashimori H, et al. Neuronal exosomal mirna-dependent translational regulation of astroglial glutamate transporter glt1. J Biol Chem. 2013;288(10):7105–7116.
   PubMed Web of Science ®Google Scholar
• Lai CPK, Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol. 2012;3:228.
   PubMed Web of Science ®Google Scholar
• Salvi V, Gianello V, Busatto S, et al. Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7. JCI Insight. 2018;3(10):98204.
   PubMed Web of Science ®Google Scholar
• Li L, Li C, Wang S, et al. Exosomes derived from hypoxic oral squamous cell carcinoma cells deliver miR-21 to normoxic cells to elicit a prometastatic phenotype. Cancer Res. 2016;76(7):1770–1930.
   PubMed Web of Science ®Google Scholar
• Tian T, Zhu YL, Zhou YY, et al. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014;289(32):22258–22267.
   PubMed Web of Science ®Google Scholar
• Su MJ, Aldawsari H, Amiji M. Pancreatic cancer cell exosome-mediated macrophage reprogramming and the role of MicroRNAs 155 and 125b2 transfection using nanoparticle delivery systems. Sci Rep. 2016;6:30110.
   PubMed Web of Science ®Google Scholar
• Munoz JL, Bliss SA, Greco SJ, et al. Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity. Mol Ther – Nucleic Acids. 2013;2:126.
   Google Scholar
• Feng Y, Huang W, Wani M, et al. Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One. 2014;9(2):e88685.
   PubMed Web of Science ®Google Scholar
• Chen L, Charrier A, Zhou Y, et al. Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology. 2014;59(3):1118–1129.
   PubMed Web of Science ®Google Scholar
• Yuyama K, Igarashi Y. Exosomes as carriers of Alzheimer’s amyloid-ß. Front Neurosci. 2017;11:229.
   PubMed Web of Science ®Google Scholar
• Yuan D, Zhao Y, Banks WA, et al. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials. 2017;142:1–12.
   PubMed Web of Science ®Google Scholar
• Vashisht M, Rani P, Onteru SK, et al. Curcumin encapsulated in milk exosomes resists human digestion and possesses enhanced intestinal permeability in vitro. Appl Biochem Biotechnol. 2017;183(3):993–1007.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 2011;19(10):1769–1779.
   PubMed Web of Science ®Google Scholar
• Kalani A, Chaturvedi P, Kamat PK, et al. Curcumin-loaded embryonic stem cell exosomes restored neurovascular unit following ischemia-reperfusion injury. Int J Biochem Cell Biol. 2016;79:360–369.
   PubMed Web of Science ®Google Scholar
• Ju S, Mu J, Dokland T, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther. 2013;21(7):1345–1357.
   PubMed Web of Science ®Google Scholar
• Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359(6382):1350–1355.
   PubMed Web of Science ®Google Scholar
• Gajewski TF. Cancer immunotherapy. Mol Oncol. 2012;6(2):242–250.
   PubMed Web of Science ®Google Scholar
• Chaput N, Théry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol. 2011;33(5):419–440.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73(10):1907–1920.
   PubMed Web of Science ®Google Scholar
• Wahlund CJE, Güclüler G, Hiltbrunner S, et al. Exosomes from antigen-pulsed dendritic cells induce stronger antigen-specific immune responses than microvesicles in vivo. Sci Rep. 2017;7:1–9.
   PubMed Web of Science ®Google Scholar
• Greening DW, Gopal SK, Xu R, et al. Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol. 2015;40:72–81.
   PubMed Web of Science ®Google Scholar
• Roccaro AM, Sacco A, Maiso P, et al. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest. 2013;123(4):1542–1555.
   PubMed Web of Science ®Google Scholar
• Lundholm M, Schröder M, Nagaeva O, et al. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: Mechanism of immune evasion. PLoS One. 2014;9(9):e108925.
   PubMed Web of Science ®Google Scholar
• Qi J, Zhou Y, Jiao Z, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through Hedgehog signaling pathway. Cell Physiol Biochem. 2017;42(6):2242–2254.
   PubMedGoogle Scholar
• Frydrychowicz M, Kolecka-Bednarczyk A, Madejczyk M, et al. Exosomes-structure, biogenesis and biological role in non-small-cell lung cancer. Scand J Immunol. 2015;81(1):2–10.
   PubMed Web of Science ®Google Scholar
• Purushothaman A, Bandari SK, Liu J, et al. Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions. J Biol Chem. 2016;291(4):1652–1663. 2015/11/24.
   PubMed Web of Science ®Google Scholar
• Shah R, Patel T, Freedman J. Circulating extracellular vesicles in human disease. N Engl J Med. 2018;379(10):958–966.
   PubMed Web of Science ®Google Scholar
• Van den Boorn JG, Daßler J, Coch C, et al. Exosomes as nucleic acid nanocarriers. Adv Drug Deliv Rev. 2013;65(3):331–335.
   PubMed Web of Science ®Google Scholar
• Tan A, De La Peña H, Seifalian AM. The application of exosomes as a nanoscale cancer vaccine. Int J Nanomedicine. 2010;5:889–900.
   PubMed Web of Science ®Google Scholar
• Li R, Chibbar R, Xiang J. Novel EXO-T vaccine using polyclonal CD4(+) T cells armed with HER2-specific exosomes for HER2-positive breast cancer. Onco Targets Ther. 2018;11:7089–7093.
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang C, Wei W, et al. Dendritic cells pulsed with leukemia cell-derived exosomes more efficiently induce antileukemic immunities. PLoS One. 2014;9(3):e91463–e91463.
   Web of Science ®Google Scholar
• Taghikhani A, Hassan ZM, Ebrahimi M, et al. microRNA modified tumor-derived exosomes as novel tools for maturation of dendritic cells. J Cell Physiol. 2019;234(6):9417–9427.
   PubMed Web of Science ®Google Scholar
• Jesus S, Soares E, Cruz MT, et al. Exosomes as adjuvants for the recombinant hepatitis B antigen: First report. Eur J Pharm Biopharm. 2018;133:1–11.
   PubMed Web of Science ®Google Scholar
• Anticoli S, Manfredi F, Chiozzini C, et al. An exosome-based vaccine platform imparts cytotoxic t lymphocyte immunity against viral antigens. Biotechnol J. 2018;13(4):1700443.
   Web of Science ®Google Scholar
• Jella K, Nasti T, Li Z, et al. Exosomes, their biogenesis and role in inter-cellular communication, tumor microenvironment and cancer immunotherapy. Vaccines. 2018;6(4):69.
   Web of Science ®Google Scholar
• Tan A, Rajadas J, Seifalian AM. Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev. 2013;65(3):357–367.
   PubMed Web of Science ®Google Scholar
• Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4(3):214–222.
   PubMed Web of Science ®Google Scholar
• Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27(3):172–188.
   PubMed Web of Science ®Google Scholar
• Frühbeis C, Fröhlich D, Kuo WP, et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol. 2013;11(7):e1001604.
   PubMed Web of Science ®Google Scholar
• Barrachina MN, Calderón-Cruz B, Fernandez-Rocca L, et al. Application of extracellular vesicles proteomics to cardiovascular disease: guidelines, data analysis, and future perspectives. Proteomics. 2019;19(1-2):1800247.
   Web of Science ®Google Scholar
• Cheng H, Fan JH, Zhao LP, et al. Chimeric peptide engineered exosomes for dual-stage light guided plasma membrane and nucleus targeted photodynamic therapy. Biomaterials. 2019;211:14–24.
   PubMed Web of Science ®Google Scholar
• Barile L, Vassalli G. Exosomes: therapy delivery tools and biomarkers of diseases. Pharmacol Ther. 2017;174:63–78.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang M, Xu T, et al. Engineering bioactive self-healing antibacterial exosomes hydrogel for promoting chronic diabetic wound healing and complete skin regeneration. Theranostics. 2019;9(1):65–76.
   PubMed Web of Science ®Google Scholar